BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17885523)

  • 1. Current treatment of recurrent vasovagal syncope: between evidence-based therapy and common sense.
    Alboni P; Dinelli M; Gianfranchi L; Pacchioni F
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):835-9. PubMed ID: 17885523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurally-mediated syncope.
    Brignole M
    Ital Heart J; 2005 Mar; 6(3):249-55. PubMed ID: 15875516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overview on the management of vasovagal syncope].
    Filali T; Fehri W; Lahidheb D; Hajlaoui N; Salah O; Barakett N; Smiri Z; Mhenni H; Haouala H
    Tunis Med; 2007 Oct; 85(10):814-20. PubMed ID: 18236801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
    Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
    Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).
    van Dijk N; Quartieri F; Blanc JJ; Garcia-Civera R; Brignole M; Moya A; Wieling W;
    J Am Coll Cardiol; 2006 Oct; 48(8):1652-7. PubMed ID: 17045903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasovagal syndromes].
    Davy JM; Beck L; Pons M; Raczka F; Ferrière M
    Arch Mal Coeur Vaiss; 1998 Mar; 91 Spec No 1():33-9. PubMed ID: 9749283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expectation effect and cardiac pacing for refractory vasovagal syncope.
    Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD
    Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasovagal syncope--standards of management, clinical and diagnostic problems].
    Matyszczak-Toniak L; Kargul W
    Wiad Lek; 2007; 60(3-4):162-6. PubMed ID: 17726870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocardiology. Neurogenic syncope.
    Morillo CA; Villar JC
    Baillieres Clin Neurol; 1997 Jul; 6(2):357-80. PubMed ID: 9483298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Permanent cardiac pacing in vasovagal syncope: when and which?].
    González-Hermosillo JA
    Arch Cardiol Mex; 2006; 76 Suppl 2():S225-8. PubMed ID: 17017106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Components of clinical trials for vasovagal syncope.
    Sheldon R; Rose S
    Europace; 2001 Jul; 3(3):233-40. PubMed ID: 11467466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope.
    Brignole M; Sutton R; Menozzi C; Garcia-Civera R; Moya A; Wieling W; Andresen D; Benditt DG; Vardas P;
    Eur Heart J; 2006 May; 27(9):1085-92. PubMed ID: 16569653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of vasovagal syncope: 2004.
    Sheldon R; Morillo C; Krahn A
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):915-23. PubMed ID: 15500436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of vasovagal syncope (nonpharmacologic therapy and pharmacotherapy)].
    Mitro P
    Vnitr Lek; 2000 Dec; 46(12):861-8. PubMed ID: 11214367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurally-mediated sincope.
    Can I; Cytron J; Jhanjee R; Nguyen J; Benditt DG
    Minerva Med; 2009 Aug; 100(4):275-92. PubMed ID: 19749682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the contribution of recent clinical trials to advancement of syncope management.
    Moya A; Rivas N; Perez-Rodon J
    Prog Cardiovasc Dis; 2013; 55(4):396-401. PubMed ID: 23472777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in the treatment of neurally-mediated syncope.
    Maggi R; Brignole M
    Minerva Med; 2007 Oct; 98(5):503-9. PubMed ID: 18043560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.